Literature DB >> 1649887

Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo.

S R Green1, R C Pittman.   

Abstract

Evidence for the direct uptake ("selective uptake") of cholesteryl esters (CE) from low density lipoproteins (LDL) by perfused luteinized rat ovaries (Azhar, S., A. Cooper, L. Tsai, W. Maffe, and E. Reaven. 1988. J. Lipid Res. 29: 869-882) led to this examination of LDL selective uptake in cultured cells and in rats using LDL doubly labeled with intracellularly trapped tracers of the CE and apoB moieties. Studies in vitro demonstrated LDL selective uptake by human fibroblasts at a low rate relative to LDL particle uptake; the fractional rate of this selective uptake increased with decreasing LDL particle size. Mouse Y1-BS1 adrenal cortical tumor cells also selectively took up LDL CE; on ACTH treatment, LDL selective uptake increased in parallel with high density lipoproteins (HDL) selective uptake, and accounted for the majority of LDL CE uptake. Metabolism of doubly labeled LDL was examined in rats. Adrenal gland and liver selectively took up CE from rat LDL, as did lung and adipose tissue. Selective uptake from human LDL was at a lower fractional rate than from rat LDL, and could not be demonstrated in as many organs. Although selective uptake from LDL by ovaries of adult rats was not significant, ovaries of immature rats consistently exhibited LDL selective uptake; on treatment of these rats with hormones to produce superovulated, luteinized ovaries, LDL selective uptake increased in the ovaries and nowhere else. Selective uptake was also apparent in liver, where it accounted for 27% of total hepatic uptake of rat LDL CE. These studies indicate a significant contribution of selective uptake to LDL CE metabolism in rats, suggesting the possibility of a role in other animals as well.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649887

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.

Authors:  Martin Jansen; Peter Pfaffelhuber; Michael M Hoffmann; Gerhard Puetz; Karl Winkler
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

2.  Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall.

Authors:  Toru Seo; Kemin Qi; Chuchun Chang; Ying Liu; Tilla S Worgall; Rajasekhar Ramakrishnan; Richard J Deckelbaum
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

3.  Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.

Authors:  L Izem; E Rassart; L Kamate; L Falstrault; D Rhainds; L Brissette
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

Review 4.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

5.  Selective uptake of cholesteryl esters of low-density lipoproteins is mediated by the lipoprotein-binding site in HepG2 cells and is followed by the hydrolysis of cholesteryl esters.

Authors:  L Brissette; M C Charest; L Falstrault
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

Review 6.  n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.

Authors:  C Torrejon; U J Jung; R J Deckelbaum
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-12-03       Impact factor: 4.006

7.  n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution.

Authors:  Chuchun L Chang; Toru Seo; Mika Matsuzaki; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-05       Impact factor: 8.311

8.  SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation.

Authors:  Tatyana G Vishnyakova; Alexander V Bocharov; Irina N Baranova; Roger Kurlander; Steven K Drake; Zhigang Chen; Marcelo Amar; Denis Sviridov; Boris Vaisman; Eugenia Poliakov; Alan T Remaley; Thomas L Eggerman; Amy P Patterson
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.